Geron Stock

Geron P/E

The (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Geron (GERN) as of Aug 13, 2026 is -12.28. In the previous year, (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. was -6.03 — a change of 103.51% (lower).

P/E

-12.28

YoY

103.51%

Last updated:

As of Aug 13, 2026, Geron's P/E ratio was -12.28, a 103.51% change from the -6.03 P/E ratio recorded in the previous year.

The Geron P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/E
Date
P/E
Jan 1, 2019
-4.25 base
Jan 1, 2020
-6.70 base
Jan 1, 2021
-3.48 base
Jan 1, 2022
-6.96 base
Jan 1, 2023
-6.82 base
Jan 1, 2024
-13.10 base
Jan 1, 2025
-10.27 base
Jan 1, 2026 (e)
-78.28 base
YEARP/E
2026 est -78.28
2025 -10.27
2024 -13.10
2023 -6.82
2022 -6.96
2021 -3.48
2020 -6.70
2019 -4.25
2018 -6.90
2017 -3.81
2016 -4.14
2015 -
2014 -5.31
2013 -2.13
2012 -0.35
2011 -0.11
2010 -0.27
2009 -0.42
2008 -0.35
2007 -0.69
2006 -1.10
Access this data via the Eulerpool API

Geron Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Geron's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Geron's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Geron's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Geron grows earnings faster than its peers.

Geron Stock analysis

What does Geron do? Geron Corp is a biopharmaceutical company headquartered in Menlo Park, California, founded in 1990. The company's goal is to develop innovative products and therapies that have the potential to combat serious diseases. Geron Corp specializes in the research of embryonic stem cells. The company is a pioneer in researching technologies for the use of stem cells and has made significant breakthroughs in the field of regenerative medicine. By developing new stem cell therapies, Geron Corp aims to improve the lives of patients with serious conditions such as cancer, Parkinson's disease, and spinal cord injuries. Geron Corp operates various business segments, including oncology, regenerative medicine, and RNA-based therapies. In the field of oncology, the company focuses on developing therapies for the treatment of cancer, particularly solid tumors. One of the most important developments is the drug Imetelstat, which aims to extend the telomeres of cancer cells by inhibiting the activity of telomerase. Imetelstat is currently in various clinical trials and has the potential to revolutionize the treatment of leukemia and other types of cancer. Another important business segment of Geron Corp is regenerative medicine, particularly the research of therapies for repairing spinal cord injuries. The company has made significant breakthroughs in this area and has a promising pipeline of products aimed at repairing damaged nerve cells in the spinal cord and restoring patients' mobility. Geron Corp is also a leading company in the field of RNA-based therapies. RNA-based therapies aim to regulate gene activity to treat diseases. The company has developed various innovative technologies aimed at accelerating and enhancing the development of RNA-based therapies. In recent years, Geron Corp has brought a variety of products to the market, including drugs for the treatment of spinal cord injuries, leukemia, and other types of cancer. The company has also formed partnerships with other leading companies in the biopharmaceutical industry to advance the development and commercialization of products. Overall, Geron Corp has made a significant contribution to the research and development of new technologies and therapies with the potential to improve the lives of millions of people. The company has a promising pipeline of products and is committed to further solidifying its position as a leading company in the biopharmaceutical industry. Geron is one of the most popular companies on Eulerpool.

P/E Details

Deciphering Geron's P/E Ratio

The Price to Earnings (P/E) Ratio of Geron is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Geron's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Geron is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Geron’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Geron stock

(Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Geron is -12.28 in 2026.

(Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Geron changed from -6.03 to -12.28, representing a 103.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. Geron since 2006 – with annual values, charts, and detailed analysis.

The price-earnings ratio (P/E ratio) is a key figure for evaluating a stock. The stock price is compared to the earnings per share. The ratio therefore expresses the number of years it takes for a company to generate the current earnings to match the stock price.

P/E ratio formula:
P/E ratio = Stock price / Earnings per Share (EPS)
If the earnings per share (EPS) is not readily available, it can be calculated by dividing the company's total earnings by the number of shares issued.

EPS formula:
Total earnings of the company / Number of shares issued
The earnings per share (EPS) can usually be easily found on most financial websites.

The P/E ratio is one of the most commonly used indicators for valuing stocks. However, the correct application of the P/E ratio is slightly more complicated than the formula described above would suggest. Therefore, it is always only a snapshot and not a reliable consideration of the future. If future earnings were to increase without any change in the stock price, the P/E ratio would accordingly decrease.

To evaluate (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account.'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account..

A 'good' varies by industry and company stage. On Eulerpool, you can compare (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account.'s Geron with sector peers and the industry average to assess whether it is attractive.

The P/E ratio in evaluating a stock.

The price-earnings ratio (P/E ratio) is an important financial ratio that is often used by investors to assess the attractiveness of a stock. It is an indicator of a company's earnings and valuation, and provides an indication of whether a stock is overvalued or undervalued. It is also used as an indicator of whether a stock is "expensive" or "cheap".

History of P/E ratio

The P/E ratio was first used in 1881 by the famous financial scientist Benjamin Graham. He developed the P/E ratio as a means to evaluate whether a stock is trading at a "good" or "bad" price. Since then, the P/E ratio has had a long history in the financial world, particularly among investors who are looking for a way to evaluate stocks in an informed manner.

Calculation of the P/E ratio

The P/E ratio is calculated by dividing the current stock price by the earnings per share. A simple formula for calculating the P/E ratio is as follows:

P/E ratio = Stock price / Earnings per share

Example: If a stock is traded at the current price of $10 and the earnings per share is $1, the P/E ratio would be 10 ($10 / $1 = 10).

Application of the P/E ratio

Investors use the P/E ratio to assess the attractiveness of a stock. A high P/E ratio can indicate that a stock is overvalued, while a low P/E ratio means that a stock is undervalued. Investors can then decide whether to buy, sell, or hold a stock based on this information. Another reason why investors use the P/E ratio is to check how stocks perform compared to other stocks or the market as a whole. If a stock's P/E ratio is higher than the overall market's P/E ratio, this may mean that the stock is overvalued, and investors can decide whether to sell or hold the stock. Investors usually also use the P/E ratio to compare stocks over time. If a stock has a P/E ratio of 10 and a year later has a P/E ratio of 20, this may mean that the stock is overvalued. Investors can then decide whether to hold or sell the stock.

Advantages and Disadvantages of using the P/E ratio

BenefitsThe P/E ratio is a useful tool to assess the attractiveness of a stock and to evaluate how a stock is performing compared to the market. It is a simple tool that can assist investors in deciding whether to buy, sell, or hold a stock.

DisadvantagesThe P/E ratio is a simple tool that does not provide any information about the future performance of a stock. It can be difficult to predict the future performance of a stock, and sometimes the P/E ratio can give a false picture of a stock. Therefore, investors must be cautious when relying on the P/E ratio.

In addition, the P/E ratio can vary depending on the industry, which makes comparability difficult. For example, a stock in a certain industry may have a low P/E ratio, while another stock in a different industry may have a higher P/E ratio. Therefore, investors must be cautious when relying on the P/E ratio.

Conclusion

The P/E ratio is a useful tool that can assist investors in assessing the attractiveness and value of a stock. It can also be used to check how a stock is performing in comparison to the market. However, it is important to note that it is a simple tool that does not make any statement about the future performance of a stock, and investors must be cautious when relying on the P/E ratio.

Access this data via the Eulerpool API

Valuation — Geron

All Key Metrics — Geron